Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from PuraPharm Corp. Ltd. ( (HK:1498) ) is now available.
PuraPharm Corporation Limited has announced the composition of its board of directors, highlighting the roles and functions of each member. This announcement provides clarity on the leadership structure, which is crucial for stakeholders to understand the governance and strategic direction of the company.
The most recent analyst rating on (HK:1498) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on PuraPharm Corp. Ltd. stock, see the HK:1498 Stock Forecast page.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and distribution of traditional Chinese medicine products.
Average Trading Volume: 221,525
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.7M
For a thorough assessment of 1498 stock, go to TipRanks’ Stock Analysis page.